Skip to main content
Top
Published in: Current Dermatology Reports 1/2012

01-03-2012 | Epidemiology (J Gelfand, Section Editor)

Impact of Long-Term Antibiotic Use for Acne on Bacterial Ecology and Health Outcomes: A Review of Observational Studies

Authors: Jackie P-D. Garrett, David J. Margolis

Published in: Current Dermatology Reports | Issue 1/2012

Login to get access

Abstract

Acne is among the most common cutaneous disorder affecting most individuals by the time they reach adulthood. Management of acne can be quite a challenge and includes medications with significant side effects. We discuss the potential side effects of long-term antibiotic use. These side effects should be carefully weighed and monitored when designing a treatment plan.
Literature
1.
go back to reference Bowe WP, Leyden JJ, Crerand CE, Sarwer DB, Margolis DJ. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol. 2007;57(2):222–30. Epub 2007/05/15.PubMedCrossRef Bowe WP, Leyden JJ, Crerand CE, Sarwer DB, Margolis DJ. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol. 2007;57(2):222–30. Epub 2007/05/15.PubMedCrossRef
2.
go back to reference Williams HC, Dellavalle RP, Garner S (2011) Acne vulgaris. Lancet. Epub 2011/09/02. Williams HC, Dellavalle RP, Garner S (2011) Acne vulgaris. Lancet. Epub 2011/09/02.
3.
go back to reference Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. JDD. 2010;9(6):655–64. Epub 2010/07/22.PubMed Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. JDD. 2010;9(6):655–64. Epub 2010/07/22.PubMed
4.
go back to reference Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535–41. Epub 2002/07/23.PubMed Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535–41. Epub 2002/07/23.PubMed
5.
go back to reference Webster GF. Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology. 1998;196(1):80–1. Epub 1998/04/29.PubMedCrossRef Webster GF. Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology. 1998;196(1):80–1. Epub 1998/04/29.PubMedCrossRef
6.
go back to reference Dutil M. Benzoyl peroxide: enhancing antibiotic efficacy in acne management. Skin Therapy Letter. 2010;15(10):5–7. Epub 2010/11/16.PubMed Dutil M. Benzoyl peroxide: enhancing antibiotic efficacy in acne management. Skin Therapy Letter. 2010;15(10):5–7. Epub 2010/11/16.PubMed
7.
go back to reference Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2001;33(6):757–62. Epub 2001/08/21.CrossRef Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2001;33(6):757–62. Epub 2001/08/21.CrossRef
8.
go back to reference Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. 2005;141(9):1132–6.PubMedCrossRef Margolis DJ, Bowe WP, Hoffstad O, Berlin JA. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. 2005;141(9):1132–6.PubMedCrossRef
9.
go back to reference Bowe WP, Hoffstad O, Margolis DJ. Upper respiratory tract infection in household contacts of acne patients. Dermatology. 2007;215(3):213–8.PubMedCrossRef Bowe WP, Hoffstad O, Margolis DJ. Upper respiratory tract infection in household contacts of acne patients. Dermatology. 2007;215(3):213–8.PubMedCrossRef
10.
go back to reference •• Margolis DJ, Fannelli M, Kupperman E, Papadopoulos M, Joshua M et al. Association of pharyngitis with oral antibiotic use for the treatment of acne: A cross-sectional and prospective cohort study. Archives of dermatology. Epub 2011/10/24. This is a study of the incidence of pharyngitis and antibiotic use for the treatment of acne. No association was noted with group A streptococcus. •• Margolis DJ, Fannelli M, Kupperman E, Papadopoulos M, Joshua M et al. Association of pharyngitis with oral antibiotic use for the treatment of acne: A cross-sectional and prospective cohort study. Archives of dermatology. Epub 2011/10/24. This is a study of the incidence of pharyngitis and antibiotic use for the treatment of acne. No association was noted with group A streptococcus.
11.
go back to reference •• Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ. Antibiotics, acne, and Staphylococcus Aureus colonization. Arch. Dermatol. 2011;147(8):917–21. Epub 2011/04/13. This is a study of the frequency of Staphylococcus aureus colonization among patients with acne. It examined the antibiotic susceptibility patterns between the patients who are using antibiotics and those who are not using antibiotics. •• Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ. Antibiotics, acne, and Staphylococcus Aureus colonization. Arch. Dermatol. 2011;147(8):917–21. Epub 2011/04/13. This is a study of the frequency of Staphylococcus aureus colonization among patients with acne. It examined the antibiotic susceptibility patterns between the patients who are using antibiotics and those who are not using antibiotics.
12.
go back to reference Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. JCAD. 2011;4(2):40–7. Epub 2011/03/10. Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. JCAD. 2011;4(2):40–7. Epub 2011/03/10.
13.
go back to reference Borchers AT, Keen CL, Gershwin ME. Drug-induced lupus. Ann New York Acad Sci. 2007;1108:166–82. Epub 2007/09/26.CrossRef Borchers AT, Keen CL, Gershwin ME. Drug-induced lupus. Ann New York Acad Sci. 2007;1108:166–82. Epub 2007/09/26.CrossRef
14.
go back to reference Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systematic review. Dermatology. 2000;200(3):223–31. Epub 2000/06/01.PubMedCrossRef Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systematic review. Dermatology. 2000;200(3):223–31. Epub 2000/06/01.PubMedCrossRef
15.
go back to reference Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med. 1999;159(5):493–7. Epub 1999/03/13.PubMedCrossRef Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med. 1999;159(5):493–7. Epub 1999/03/13.PubMedCrossRef
16.
go back to reference Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between Tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol. 2007;157(3):540–6. Epub 2007/06/29.PubMedCrossRef Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between Tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol. 2007;157(3):540–6. Epub 2007/06/29.PubMedCrossRef
17.
go back to reference Schoonen WM, Thomas SL, Somers EC, Smeeth L, Kim J, Evans S, et al. Do selected drugs increase the risk of lupus? A matched case-control study. Br J Clin Pharmacol. 2010;70(4):588–96. Epub 2010/09/16.PubMedCrossRef Schoonen WM, Thomas SL, Somers EC, Smeeth L, Kim J, Evans S, et al. Do selected drugs increase the risk of lupus? A matched case-control study. Br J Clin Pharmacol. 2010;70(4):588–96. Epub 2010/09/16.PubMedCrossRef
18.
go back to reference Shale M, Kaplan GG, Panaccione R, Ghosh S. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut. 2009;58(6):737–41. Epub 2009/05/13.PubMedCrossRef Shale M, Kaplan GG, Panaccione R, Ghosh S. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut. 2009;58(6):737–41. Epub 2009/05/13.PubMedCrossRef
19.
go back to reference • Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. The American journal of gastroenterology. 2009;104(11):2774–8. Epub 2009/07/23. An association between isotretinoin use and inflammatory bowel disease was not noted in this study. • Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. The American journal of gastroenterology. 2009;104(11):2774–8. Epub 2009/07/23. An association between isotretinoin use and inflammatory bowel disease was not noted in this study.
20.
go back to reference • Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. The American journal of gastroenterology. 2010;105(9):1986-93. Epub 2010/04/01. An association between inflammatory bowel disease and isotretinoin use was noted in this study. • Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. The American journal of gastroenterology. 2010;105(9):1986-93. Epub 2010/04/01. An association between inflammatory bowel disease and isotretinoin use was noted in this study.
21.
go back to reference • Card T, Logan RFA, Rodrigues LC e t al. Antibiotic use and the development of Crohn’s disease. Gut 2004;53:246–50. This is one of the first studies to describe the association between antibiotics and inflammatory bowel disease. • Card T, Logan RFA, Rodrigues LC e t al. Antibiotic use and the development of Crohn’s disease. Gut 2004;53:246–50. This is one of the first studies to describe the association between antibiotics and inflammatory bowel disease.
22.
go back to reference Margolis DJ, Fannelli M, Hoffstad O, Lewis J. Potential association between oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol. 2010;105(12):2610–6. Epub2010/8/10.PubMedCrossRef Margolis DJ, Fannelli M, Hoffstad O, Lewis J. Potential association between oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol. 2010;105(12):2610–6. Epub2010/8/10.PubMedCrossRef
23.
go back to reference Cornish JA, Tan E, Simillis C, Clark SK, Teare J, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394–400.PubMedCrossRef Cornish JA, Tan E, Simillis C, Clark SK, Teare J, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394–400.PubMedCrossRef
24.
go back to reference Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291(7):827–35. Epub 2004/02/19.PubMedCrossRef Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA. 2004;291(7):827–35. Epub 2004/02/19.PubMedCrossRef
25.
go back to reference Friedman GD, Oestreicher N, Chan J, Quesenberry CP, Jr., Udaltsova N, Habel LA. Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006;15(11):2102–6. Epub 2006/11/23. Friedman GD, Oestreicher N, Chan J, Quesenberry CP, Jr., Udaltsova N, Habel LA. Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006;15(11):2102–6. Epub 2006/11/23.
26.
go back to reference Zhang H, Garcia Rodriguez LA, Hernandez-Diaz S. Antibiotic use and the risk of lung cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008;17(6):1308–15. Epub 2008/06/12. Zhang H, Garcia Rodriguez LA, Hernandez-Diaz S. Antibiotic use and the risk of lung cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008;17(6):1308–15. Epub 2008/06/12.
Metadata
Title
Impact of Long-Term Antibiotic Use for Acne on Bacterial Ecology and Health Outcomes: A Review of Observational Studies
Authors
Jackie P-D. Garrett
David J. Margolis
Publication date
01-03-2012
Publisher
Current Science Inc.
Published in
Current Dermatology Reports / Issue 1/2012
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-011-0001-7

Other articles of this Issue 1/2012

Current Dermatology Reports 1/2012 Go to the issue

Epidemiology (J Gelfand, Section Editor)

Comorbidity in Atopic Dermatitis

Epidemiology (J Gelfand, Section Editor)

The Epidemiology and Prevention of Herpes Zoster